The mRNA vaccines used against COVID were never designed to battle the omicron variant, a now dominant strain of the coronavirus that recently claimed 18,000 lives in a single week. Yet individuals who receive their third ...
Jun 23, 2022
0
85
For healthy adults, the bivalent prefusion F respiratory syncytial virus (RSVpreF) vaccine is effective against symptomatic RSV infection and viral shedding, according to a study published in the June 23 issue of the New ...
Jun 23, 2022
0
17
Rwanda and German pharma company BioNTech broke ground Thursday on Africa's first mRNA vaccine factory where cutting-edge treatments for diseases like COVID-19 will be made for millions across the continent.
Jun 23, 2022
0
2
The EU's medicines watchdog on Thursday approved Valneva's anti-COVID jab, Europe's sixth green-lit coronavirus vaccine, which uses more traditional technology than others on the market which the firm hopes will reduce jab ...
Jun 23, 2022
0
2
A research team led by Prof. Dr. Tamam Bakchoul from the Institute for Clinical and Experimental Transfusion Medicine (IKET) at the University Hospital of Tübingen is investigating the suitability of anticoagulants in patients ...
Jun 23, 2022
0
2
Colorectal, pancreatic, esophageal and stomach cancers—some of the deadliest kinds of cancer—have high recurrence rates where the cancer comes back even after successful surgery or radiation treatment.
Jun 23, 2022
0
833
As the lone laboratory manufacturing a licensed vaccine against monkeypox, Danish company Bavarian Nordic has seen its order book fill up as the usually rare disease spreads around the world.
Jun 23, 2022
0
3
COVID-19 vaccination is not associated with an increased risk of heart attack or stroke in patients with established cardiovascular disease, according to a large study published today in Cardiovascular Research.
Jun 23, 2022
0
3
Americans 65 and older should get newer, souped-up flu vaccines because regular shots don't provide them enough protection, a federal advisory panel said Wednesday.
Jun 22, 2022
0
10
Moderna on Wednesday said its new COVID booster candidate, which it is hoping to get approved this fall, performed well against Omicron's latest subvariants.
Jun 22, 2022
0
2
